163 results on '"de Vassal F"'
Search Results
2. A Study of the Prognostic Factors of Central Nervous System Leukaemia in Acute Lymphoid Leukaemia Patients
3. Combination of Adriamycine, VM 26, Cyclophosphamide & Prednisone (AVmCP) in Chemotherapy of Lympho & Reticulum Cell Sarcoma (Stages & Topographic Forms III & IV)
4. Comparison of the Combinations a) PDN + VCR°, b) PDN + VCR°→ADMx, c) PDN + VCR°→ADMx →CARx; and d) PDN + VCR + ASP° in Induction of First Remission of Acute Lymphoid Leukemia
5. An Intensive Chemo- or Chemoimmunotherapy Regimen for Patients with Intermediate and Poor-Prognosis Acute Lymphatic Leukemia and Leukemic Lymphoblastic Lymphosarcoma: Preliminary Results with 14-Month Median Follow-Up
6. Phase II Trial of Aclacinomycin in Acute Leukemia and Lymphosarcoma
7. Vindesine: A New Vinca Alkaloid
8. Some New Chemotherapeutic Agents and Combinations Possibly Available for New Adjuvant Therapies of Minimal Disease
9. Results in Children of Acute Lymphoid Leukemia: Protocol ICIG-ALL 9 Consisting of Chemotherapy for Only 9 Months Followed by Active Immunotherapy
10. Pathogen-Free Isolation Unit: Three Years' Experience
11. Methods and Strategy for the Treatment1 of Acute Lymphoblastic Leukemia
12. Five Years Experience of the Clinical Use of a Pathogen-Free Isolation Unit
13. Comparative Results Obtained in the Treatment of Acute Lymphoid Leukemia, Acute Myeloid Leukemia, and Acute Monocytoid Leukemia
14. Attempts at Immunotherapy of 100 Acute Lymphoid Leukemia Patients: Some Factors Influencing Results
15. Nonspecific Immune Responses in Hematosarcomas and Acute Leukemias
16. Remission Induction with Poly IC in Patients with Acute Lymphoblastic Leukemia (Preliminary Results)
17. Adriamycin in the Treatment of Acute Leukemias
18. Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomas
19. Preliminary results of chemo-radiotherapy followed or not by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma: Correlation of the results with WHO categorisation
20. 1975 current results of the first 100 cytologically typed acute lymphoid leukemia submitted to BCG active immunotherapy
21. Results in children of acute lymphoid leukaemia protocol ICIG-ALL 9 consisting of chemotherapy for only nine months followed by active immunotherapy: Comparison with the results of more prolonged chemotherapy protocols recognition of two groups of acute lymphoid leukaemias from prognostic parameters
22. Long-Term Administration of Vindesine in Maintenance Regimen for Acute Lymphoblastic Leukemia (ALL) with Poor Prognosis. Apparent Lack of Long-Term Cumulative Neurotoxicity
23. Some New Chemotherapeutic Agents and Combinations Possibly Available for New Adjuvant Therapies of Minimal Disease
24. IMMUNOTHERAPY VERSUS CHEMOIMMUNOTHERAPY AS ADJUVANT TREATMENT OF MALIGNANT MELANOMA
25. Nonspecific Immune Responses in Hematosarcomas and Acute Leukemias
26. Five Years Experience of the Clinical Use of a Pathogen-Free Isolation Unit
27. Attempts at Immunotherapy of 100 Acute Lymphoid Leukemia Patients: Some Factors Influencing Results
28. New Results of Active Immunotherapy of Acute Lymphoid Leukaemia
29. Preliminary Data on Acute Leukemia Treatment with ICRF 159
30. Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas.
31. Preliminary results of three protocols for the treatment of acute lymphoid leukaemia of children: Distinction of two groups of patients according to predictable prognosis.
32. Treatment of acute myeloid leukemia with a combination of intensive induction chemotherapy, early consolidation, splenectomy and long-term maintenance chemotherapy.
33. Mechanisms of Action of Drugs Affecting Immune Responses
34. Immunotherapy of Leukemia: New Experimental and Clinical Data on Leukaemia Immunotherapy
35. Mechanisms of Action of Drugs Affecting Immune Responses: Attempts at Stimulation of Immune Response in Acute Lymphoid Leukæmia
36. Leukaemic conversion of non-Hodgkin's malignant lymphomata
37. SPLENECTOMY AND KARYOTYPIC CONVERSION IN CHRONIC MYELOID LEUKÆMIA
38. Remission Induction in Acute Lymphoid and Acute Myeloid LeukÆmias
39. Study of nitrosourea glycosyl analogs—V. An oriented phase II trial of RFCNU
40. Active immunotherapy trials on acute lymphoid leukemia lymphosarcoma and acute myeloid leukemia
41. Immunotherapy of Leukemia
42. Mechanisms of Action of Drugs Affecting Immune Responses
43. NEW ANTIGENS IN HUMAN LEUKÆMIC CELLS, AND ANTIBODY IN THE SERUM OF LEUKÆMIC PATIENTS
44. ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIA
45. Hydroxyurea, Leucopheresis, and Splenectomy in Chronic Myeloid Leukaemia at the Problastic Phase
46. CHAPTER 35 - IMMUNOTHERAPY VERSUS CHEMOIMMUNOTHERAPY AS ADJUVANT TREATMENT OF MALIGNANT MELANOMA
47. Phase I-II study of aclarubicin for treatment of acute myeloid leukaemia.
48. [Prevention of leukemic meningitis].
49. [Letter: High remission rate in acute myeloid leukemia (AML) by adriamycin, vincristine and cytosine arabinoside combination. Importance of intensive hematological care].
50. [Leukaemias and lymphomas treatment by vindesine. Result of a phase II trial in terms of remission induction (author's transl)].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.